Temazepam: uses, dosing, side effects & brands

Temazepam is a benzodiazepine used to treat Depressive Disorder, Sleep Initiation and Maintenance Disorders, Panic Disorder.

The FDA classifies temazepam as a benzodiazepine. Benzodiazepines boost the brain's main calming chemical, GABA, by binding to the GABA-A receptor and making its chloride channel open more often. This quiets nerve activity, producing sedation, reduced anxiety, muscle relaxation, and protection against seizures. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run temazepam against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

Across the brands we track, temazepam is currently marketed as capsule, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

Yes. Our catalog lists 1 generic temazepam product alongside the brand versions. A generic has the same active ingredient and must meet the FDA's bioequivalence standard; it usually costs less. Ask your pharmacist which one your plan covers.

Drowsiness is the standout — 9.1% versus 5.6% on placebo in the trials — along with lethargy (4.5% vs 3.4%), dizziness (4.5% vs 3.3%), and next-day hangover (2.5% vs 1.1%). Headache and fatigue were reported too, but at rates matching or below placebo, so they're weak markers of the drug itself. The one that catches people out is next-morning grogginess and impaired driving, since temazepam is still active for hours after you wake up. The label is specific about how to use it: take the capsule immediately before getting into bed, and only when you can devote a full night to sleep before you need to be alert again. Don't take it after already lying awake for hours — that's how a dose lands too close to morning. Older adults face an added risk of falls and should generally use lower doses.

Three. (1) Combining benzodiazepines with opioids can cause profound sedation, respiratory depression, coma, and death — this covers prescription painkillers like oxycodone and hydrocodone, and also cough syrups containing codeine. (2) Abuse, misuse, and addiction, which can lead to overdose and death; the severe reactions reported with benzodiazepine abuse and misuse include delirium, paranoia, suicidal thoughts and behavior, seizures, coma, and breathing difficulty. (3) Physical dependence and withdrawal, with risk rising the longer you take it and the higher the daily dose. Alcohol and other sedatives compound all three. If a new prescriber offers you an opioid, say out loud that you take temazepam.

Abrupt discontinuation or a rapid dose cut after continued use can precipitate acute withdrawal reactions that are life-threatening — seizures among them. Some people develop a protracted withdrawal syndrome with symptoms lasting weeks to more than twelve months. That's why coming off temazepam is a planned, gradual taper set by your prescriber, not something to attempt over a weekend, and why running out of refills unexpectedly is a problem worth calling about before the last capsule. If you've been taking it nightly for more than a few weeks, book the taper conversation now rather than after you decide you want to stop.

Complex sleep behaviors: sleepwalking, sleep-driving, cooking, eating, making phone calls, or having sex while not fully awake, usually with no memory of it afterward. One episode is enough to call your prescriber about stopping — alcohol and other CNS depressants make these more likely. Also call for memory gaps, confusion, hallucinations, agitation, or new or worsening depression and suicidal thoughts. Call 911 for swelling of the face, lips, tongue, or throat, or trouble breathing, which can indicate a severe allergic reaction. And if you are pregnant, might be, or are planning to become pregnant, call the prescriber before your next dose: temazepam capsule labeling contraindicates use in women who are or may become pregnant (Pregnancy Category X), and use late in pregnancy can leave a newborn sedated or in withdrawal. Make that call rather than stopping cold on your own — after regular use, the withdrawal risk above is real.

It's approved for short-term treatment of insomnia — generally 7 to 10 days. The label makes a useful point about that limit: failure of insomnia to remit after 7 to 10 days of treatment may indicate a primary psychiatric or medical illness — untreated depression, sleep apnea, pain, restless legs, thyroid disease — that should be evaluated rather than covered with a longer prescription. Its safety and effectiveness beyond about two weeks have not been established. Practical next step if you're past that window: ask about cognitive behavioral therapy for insomnia (CBT-I), which has durable effects that don't fade or require a taper, and use it as the bridge while you and your prescriber plan how to reduce the temazepam.

Temazepam is an intermediate-acting benzodiazepine with an elimination half-life of about 8–15 hours (FDA label), so most of a dose clears within roughly 2–3 days. In urine it and its metabolites are commonly detectable for about 1–7 days after use; frequent or higher-dose use pushes toward the longer end. In blood it is usually measurable for about 1–2 days. Windows are approximate and depend on dose, duration of use, age, kidney/liver function, and metabolism. This is general information, not medical or legal advice.

Yes. Temazepam is a true benzodiazepine and generally shows up on benzodiazepine urine immunoassays, and it is also a metabolite of diazepam, so a temazepam-positive result can appear after diazepam use as well. Confirmatory testing (GC-MS or LC-MS/MS) can distinguish the specific drug. If you take temazepam by prescription, disclose it to the lab or medical review officer so the result is interpreted correctly. Detection depends on the assay's cutoff and your dosing; this is not medical or legal advice.

In oral fluid (saliva), temazepam is typically detectable for about 1–2 days after a dose, making saliva a shorter-window, more recent-use test. In hair, benzodiazepines including temazepam can be detected for up to about 90 days by specialized LC-MS/MS analysis used mainly in forensic contexts. Both are approximate and affected by dose, frequency, and individual factors. Ranges reflect standard toxicology references (LabCorp, Quest, Mayo); this is educational, not medical or legal advice.